We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $2.72B
1-Year Est. Return 47.27%
This Fund
S&P 500
This Quarter Est. Return
+2.24%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$2.51B
AUM Growth
-$82.4M
Cap. Flow
-$100M
Cap. Flow %
-4%
Top 10 Hldgs %
22.43%
Holding
1,530
New
76
Increased
658
Reduced
739
Closed
53

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$7.83M
2
DD icon
DuPont de Nemours
DD
+$6.5M
3
ABBV icon
AbbVie
ABBV
+$5.98M
4
CELG
Celgene Corp
CELG
+$3.68M
5
NFLX icon
Netflix
NFLX
+$3.26M

Sector Composition

Rank Sector Weight
1 Technology 26.5%
2 Healthcare 18.58%
3 Financials 10.77%
4 Communication Services 10.27%
5 Consumer Discretionary 9.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CL icon
276
Colgate-Palmolive
CL
$72.6B
$1.51M 0.06%
21,042
-1,535
-7% -$110K
CTAS icon
277
Cintas
CTAS
$82.4B
$1.5M 0.06%
35,244
+1,428
+4% +$59.2K
VSM
278
DELISTED
Versum Materials, Inc.
VSM
$1.5M 0.06%
39,935
+3,122
+8% +$119K
CME icon
279
CME Group
CME
$92.2B
$1.5M 0.06%
9,281
-1,753
-16% -$279K
XEL icon
280
Xcel Energy
XEL
$51B
$1.5M 0.06%
32,989
-11,831
-26% -$527K
WOLF icon
281
Wolfspeed
WOLF
$1.2B
$1.5M 0.06%
37,088
+1,203
+3% +$45.3K
BBL
282
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
$1.49M 0.06%
37,544
-3,610
-9% -$152K
PRAH
283
DELISTED
PRA Health Sciences, Inc.
PRAH
$1.48M 0.06%
17,877
-1,794
-9% -$159K
VRSK icon
284
Verisk Analytics
VRSK
$26.4B
$1.48M 0.06%
14,251
+150
+1% +$15K
FCX icon
285
Freeport-McMoran
FCX
$90B
$1.48M 0.06%
84,108
-54,134
-39% -$1.02M
PCG icon
286
PG&E
PCG
$47.8B
$1.47M 0.06%
33,478
-11,880
-26% -$504K
PLD icon
287
Prologis
PLD
$138B
$1.47M 0.06%
23,355
-3,730
-14% -$232K
STX icon
288
Seagate
STX
$193B
$1.47M 0.06%
25,119
+1,325
+6% +$70.5K
ODFL icon
289
Old Dominion Freight Line
ODFL
$48.5B
$1.46M 0.06%
29,865
+4,089
+16% +$194K
BHP icon
290
BHP
BHP
$213B
$1.46M 0.06%
36,724
-3,531
-9% -$149K
EQIX icon
291
Equinix
EQIX
$107B
$1.45M 0.06%
3,477
-497
-13% -$209K
CI icon
292
Cigna
CI
$76.6B
$1.45M 0.06%
8,624
-317
-4% -$61.6K
GEN icon
293
Gen Digital
GEN
$15.6B
$1.44M 0.06%
55,688
+4,453
+9% +$121K
P
294
DELISTED
Pandora Media Inc
P
$1.43M 0.06%
284,649
-14,428
-5% -$68.9K
MOMO
295
Hello Group
MOMO
$869M
$1.43M 0.06%
38,263
-13,644
-26% -$434K
WMB icon
296
Williams Companies
WMB
$90.5B
$1.39M 0.06%
55,896
-9,917
-15% -$293K
ATO icon
297
Atmos Energy
ATO
$29.9B
$1.39M 0.06%
16,442
-2,891
-15% -$235K
SPGI icon
298
S&P Global
SPGI
$126B
$1.38M 0.05%
7,222
-1,246
-15% -$230K
FAST icon
299
Fastenal
FAST
$54B
$1.36M 0.05%
99,812
+48
+0% +$661
PXD
300
DELISTED
Pioneer Natural Resource Co.
PXD
$1.36M 0.05%
7,927
-1,276
-14% -$225K

Similar funds

Profund Advisors's Q1 2018 Portfolio in Review

As of Q1 2018, Profund Advisors held 1,530 positions worth $2.51B, down 3.2% from $2.59B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Profund Advisors withdrew a net $100M in Q1 2018, closing 53 positions and reducing 739 holdings. Its most notable exit was Bioverativ Inc. Common Stock, an estimated $2.76M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Profund Advisors opened a new position in Okta worth $1.55M.

  • Profund Advisors's largest Q1 2018 buy was Okta: 38,807 shares worth $1.55M.
  • Profund Advisors added most to Agilent Technologies in Q1 2018, an estimated $7.07M increase.
  • Profund Advisors's biggest Q1 2018 reduction was Amgen, cutting an estimated $7.83M.
  • Profund Advisors fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $2.76M.
  • Profund Advisors's ten largest holdings make up 22% of its $2.51B portfolio in Q1 2018.
  • Profund Advisors opened 76 new positions and closed 53 in Q1 2018.
  • Profund Advisors's portfolio value fell 3.2% quarter-over-quarter to $2.51B.

Based on Profund Advisors's 13F filing for Q1 2018, filed 14 May 2018.